Future Health and Bridge for Billions Launch Programme to Scale Health Innovation Across Emerging Markets Future Health, a global initiative by Abu Dhabi, is partnering with Bridge for Billions to…
Immunis Wins National Academy of Medicine Grand Prize for IMM01-STEM Healthy Longevity Innovation Immunis, Inc., a clinical-stage biotechnology company developing first-in-class multi-active biologics for muscle health and healthy aging, has…
ViiV Healthcare Reports Five-Year Real-World Evidence Supporting Long-Term Cabenuva Effectiveness in HIV Treatment ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, has…
Edwards Lifesciences Receives FDA Approval for PASCAL Precision System for Tricuspid Valve Repair Edwards Lifesciences Corporation (NYSE: EW), a global developer of patient-focused innovations for structural heart disease, has announced…
TG Therapeutics Highlights Seven-Year BRIUMVI Data, Positive Phase 3 ENHANCE Results and Progress in Progressive MS Research at MSToronto2026 TG Therapeutics, Inc. (NASDAQ: TGTX) has announced a series of updated…
HeartBeam Completes Enrollment in 486-Patient HEADSTART-ACS Study Ahead of Schedule to Advance 3D ECG Heart Attack Detection Technology HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac…
AngioDynamics Reports Positive DIRECT Study Results for NanoKnife IRE in Pancreatic Cancer and Announces New CPT Code for 2027 AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring…
Shionogi to Present New Fetroja®/Fetcroja® Data at IDWeek 2026 Highlighting Early Treatment Outcomes and Activity Against Drug-Resistant Gram-Negative Bacteria Shionogi & Co., Ltd., headquartered in Osaka, Japan, and led by…
Savillex Completes Acquisition of Entegris Life Sciences Fluid Management Business to Expand Single-Use Bioprocessing Portfolio Savillex, LLC, a leading provider of high-purity fluid handling solutions for life sciences and laboratory…
Cosette Pharmaceuticals Receives FDA Approval for EVOXAC® Oral Solution to Treat Dry Mouth in Adults With Sjögren’s Disease Cosette Pharmaceuticals, Inc., a U.S.-based specialty pharmaceutical company, has announced that the…
Bionyra Pharma Reports Positive Interim Phase 1 Results for Long-Acting Anti-TL1A Antibody BYN-002 Bionyra Pharma, a clinical-stage biopharmaceutical company developing next-generation biologics designed to harness multi-targeted biology for immune-mediated inflammatory…
Parse Biosciences Launches Evercode MAX to Expand Single-Cell Sequencing Capacity and Reduce Research Costs Parse Biosciences, a leading provider of scalable and accessible single-cell sequencing technologies and a QIAGEN company,…